Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

Health



COVID-19 antibodies can last up to 500 days after infection

Photo of woman getting her blood drawn. (Photo by Getty Images)

May 31, 2022

Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.

The findings were published in The Journal of Infectious Diseases.


Retired pharmacist with Huntington’s disease participates in clinical trials at UTHealth Houston

Wanting to advance science, Jon Huffman, who was diagnosed with Huntington's disease in 2014, has enrolled in multiple studies led by Erin Furr Stimming, MD, with UTHealth Houston. (Photo courtesy of Patricia Huffman)

May 26, 2022

Three generations of Jon Huffman’s family have suffered Huntington’s disease – a rare, inherited, ultimately fatal disease that causes the progressive breakdown of nerve cells in the brain and is best known for the associated involuntary movements, as well as cognitive and psychiatric symptoms. So it didn’t come as a particular surprise to Jon or Patricia Huffman, his wife of 36 years, when Jon began showing symptoms of the neurodegenerative disorder around 2007.




Hearing aids allow brother and sister to thrive

Thanks to their hearing aids and the expert care of UT Physicians specialists, Elizabeth and Elliott Maddox are now thriving. (Photo by Alyssa Duty/UT Physicians)

April 21, 2022

Elizabeth and Elliott Maddox love watching cartoons, eating snacks, and playtime, just like most other young children. However, they each have one extra step in the morning — putting in their hearing aids.




UTHealth Houston researchers awarded over $6 million in CPRIT grants

Photo of Jack Tsai, PhD, and Vanessa Schick, PhD, with UTHealth School of Public Health.

March 23, 2022

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded over $6 million to researchers with UTHealth Houston to aid in cancer prevention research. These awards will expand liver cancer prevention to persons experiencing homelessness, facilitate communication about the HPV vaccine, and find therapeutics that can help destroy gastrointestinal cancer cells.



Previous Page Page 15 of 18

More headlines »

Search UTHealth News

Use the form below to perform a new search.

Give to UTHealth